Nearly 20% of Americans, or more than 46 million adults, say they did not seek treatment for a health problem in the last year due to cost, and an equal number say that if they needed some form of healthcare today they would ...
Mar 31, 2021
0
3
The legalization of cannabis and the arrival of nonmedical fentanyl are fundamentally changing drug markets in North America. A large part of these changes relates to the ability to produce large quantities of the drugs at ...
Mar 10, 2021
0
0
In his inaugural address, President Joe Biden vowed that "help is on the way" to a nation grappling with a pandemic that has already claimed over 420,000 lives and counting. However, despite the promise of a better future, ...
Jan 28, 2021
0
2
Ted Howard started taking Truvada a few years ago because he wanted to protect himself against HIV, the virus that causes AIDS. But the daily pill was so pricey he was seriously thinking about giving it up.
Jan 6, 2021
0
1
Just like with drug costs, the amount of money people pay out-of-pocket for diagnostic tests and office visits for neurologic conditions has risen over 15 years, according to a new study published in the December 23, 2020, ...
Dec 23, 2020
0
3
Moderately increasing prescription drug prices did not affect the hospitalization risk of Medicare recipients with heart failure also enrolled in Medicare Part D pharmacy plans, according to researchers at Georgia State University.
Nov 11, 2020
0
3
Drugs prescribed to high-risk stroke patients are costing the NHS hundreds of millions each year—but they are so effective, the service is actually saving money.
Oct 29, 2020
0
3
The effects of cancer treatment on a patient's body are easy to see, whether it is a lack of hair on their head, sores on their skin or a look of fatigue on their face. And while there has been a lot of discussion around ...
Oct 6, 2020
0
2
Only about one in every 170 children take them. But 'orphan drugs' accounted for 1 in every 15 private insurance dollars spent on children's health care in the United States in 2018, according to a new study. That's up 65% ...
Oct 6, 2020
0
9
The French competition authority (AFC) on Thursday slapped a record 444 million euro ($500 million) fine on pharma groups Novartis, Roche and Genentech over market abuses in sales of macular degeneration drugs.
Sep 9, 2020
0
3
